Australia’s expert medical taskforces are urgently reviewing the latest AstraZeneca advice from Europe and the UK.
The European Union’s medical regulator has listed blood clots as a very rare side effect of the AstraZeneca vaccine, while the UK regulator has decided to offer an alternative shot for those aged under 30.
The Australian government is urgently reviewing international advice on AstraZeneca.Credit:AP
The decisions come after a review of data over a rare blood clotting condition that has been confirmed in a small number of patients following vaccination.
A federal government spokesperson said Australia’s Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation have been working closely with their international counterparts to consider the latest evidence.
“The Government has asked ATAGI and the TGA to immediately consider and advise on the latest vaccination findings out of Europe and the UK,” the spokesperson said.
“That advice will be provided to the Commonwealth Government for immediate consideration.”
The advice will be shared with the expert medical panel, the Australian Health Protection Principal Committee, which is comprised of all state and territory chief health officers and led by federal Chief Medical Officer Professor Paul Kelly.
The matter will also be discussed in national cabinet and in meetings with state and territory health ministers.
“The Australian Government places safety above all else, as it has done throughout the pandemic, and will continue to follow the medical advice in protecting Australians,” the spokesperson said.
More to come
Get our Coronavirus Update newsletter
Stay across the news you need to know related to the pandemic. Sent Monday and Thursday. Sign up here.
Most Viewed in Politics
From our partners
Source: Read Full Article